Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 11/20 | 0.54 |
| ▸ | CCKAR | P32238 | 5/20 | 0.47 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518719 | 0.93 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL1505980 | 0.90 | CCKBR (0.58) | CCKBRCCKAR | |
| SCHEMBL1505951 | 0.90 | CCKBR (0.58) | CCKBRCCKAR | |
| SCHEMBL1505952 | 0.90 | CCKBR (0.58) | CCKBRCCKAR | |
| SCHEMBL1506186 | 0.88 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL1506050 | 0.88 | CCKBR (0.56) | CCKBRCCKAR | |
| SCHEMBL6521762 | 0.88 | CCKBR (0.52) | CCKBRCCKARBDKRB1 | |
| SCHEMBL1505853 | 0.87 | CCKBR (0.58) | CCKBRCCKAR | |
| SCHEMBL6525885 | 0.86 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL1506120 | 0.85 | CCKBR (0.54) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011027156-A1 | BENZODIAZEPINE DERIVATIVES FOR TREATING HEPATITIS C INFECTION | ARROW THERAPEUTICS LIMITED (GB) | 2011-03-10 | — | — | WO | disclosed |
| US-20110059043-A1 | CHEMICAL COMPOUNDS | ARROW THERAPEUTICS LIMITED (GB) | 2011-03-10 | — | — | US | disclosed |
| US-20110059043-A1 | CHEMICAL COMPOUNDS | ARROW THERAPEUTICS LIMITED (GB) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059043-A1 | CHEMICAL COMPOUNDS | CYP2E1, CNR1, CYP3A5 | CCKBR 180/4885CCKAR 183/4885BDKRB1 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.